Dedicated to the future of cannabis, we endeavored to solve a crucial problem in cannabis production: How do you produce quality, cost-efficient medical marijuana for the global market?
Keyed in to the gainful possibilities of producing cannabis in Jamaica, Massive Therapeutics is poised to deliver needed cultivated cannabis to companies around the world who lack the resources and ideal locality to grow as profitably as we can.
Massive Therapeutics is launched by a dedicated team of world-class cannabis consultants, executives and Jamaican agricultural experts who believe in the future of this therapeutic, medicinal and lucrative crop. Based in Toronto, we brings together a team of global leaders in the industry, spanning Canada, the United States, the UK, Ireland and the Caribbean.
In Jamaica, our general management, labor and agricultural expertise is led by an experienced network of community partners, drawing on 20+ years of connection in the region.
Massive Therapeutics is entering a bellwether industry for medical and therapeutic research. As believers in cannabis, we’re dedicated to pursuing its many therapeutic, medical and economic possibilities.
Cannabis and its byproducts are used as a pivotal intervention for many therapeutic and mental health illnesses, like anxiety and chronic depression. Its effect on neurotransmitters in the brain has shown to aid in the treatment of patients with eating disorders, like anorexia and bulimia, and alleviate withdrawal from opioid addiction.
The pharmaceutical market is the fastest expanding sector of the cannabis industry. Among many other diseases, medical marijuana is used to treat Alzheimer’s, ALS, HIV/AIDS, cancer, Crohn’s disease, glaucoma, multiple sclerosis, muscle spasms, and severe and chronic pain.
In recent years, cannabis has been used to manage severe autism, and it’s proven to be a powerful treatment for epilepsy and seizure disorders.
The recreational cannabis market, boosted by Canada’s entrance as a full-scale cannabis economy in 2017, is growing at exponential speeds.
The legal cannabis market is expected to value over $93 billion by 2026, and in 2019, spending in the North American market was valued at almost $14 billion, growing by 30% in one year.
